Call for Nominations: Pan-Canadian Oncology Drug Review deadline July 31st Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, July 15, 2015

Call for Nominations: Pan-Canadian Oncology Drug Review deadline July 31st



Home 


http://www.hrassociates.ca/cadth-pcodr/CADTH_pCODR_logoa.jpg

Call for Nominations

Background

The role of the pCODR Expert Review Committee (pERC) is to assess the clinical evidence and cost-effectiveness of cancer drugs in order to make recommendations to the provinces and territories to help guide their drug funding decisions.
Composed of up to 16 members, pERC makes recommendations and provides advice to the Ministries of Health and cancer agencies.

Patient Member

pERC is looking for a Patient Member who has first-hand experience with the treatment and care of cancer or is the family member of a cancer patient and has developed a deep understanding of the treatment and care of cancer.

Desired Qualifications

The successful candidate will have personal knowledge of, experience with, and understanding of issues related to cancer and its management (diagnosis, treatment, and care).  They will also have a demonstrated understanding and appreciation of patient needs and priorities and an overall understanding of other patient issues and health care concerns that may impact cancer patient communities.    
Successful candidates should also possess the following:
  • Strong communication and interpersonal skills to be able to work constructively as a member of a team
  • Ability to act with integrity and independence  from specific interests and gain respect and credibility within a diverse range of stakeholders
  • Open-minded approach and diplomacy skills, with the ability to relate to and respect a diverse range of values and beliefs
Members of pERC are expected to prepare for and attend up to 12 meetings per year in Toronto, and comply with pCODR's Conflict of Interest and Confidentiality requirements.  No person currently employed by any pharmaceutical or related company will be considered.  Members of pERC receive a modest remuneration.
All applicants will receive confirmation of receipt of their applications.  While we thank all applicants for their submissions, only those under further consideration will be contacted personally.
All applications must be received by July 31, 2015.
For more information and how to apply, please visit www.hrassociates.ca/cadth-pcodr.
To request communication in an accessible format, please contact us at 416.237.1500 (1-866-598-1500) ext.231 or email at pcodr@hrassociates.ca.







0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.